ImmuCell Corporation (ICCC)
5.38
-0.12 (-2.18%)
At close: Apr 15, 2025, 3:59 PM
5.21
-3.16%
After-hours: Apr 15, 2025, 04:32 PM EDT
-2.18% (1D)
| Bid | 4.2 |
| Market Cap | 47.94M |
| Revenue (ttm) | 26.49M |
| Net Income (ttm) | -2.16M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -20.69 |
| Forward PE | -48.82 |
| Analyst | n/a |
| Ask | 5.82 |
| Volume | 64,095 |
| Avg. Volume (20D) | 16,316 |
| Open | 5.49 |
| Previous Close | 5.50 |
| Day's Range | 5.20 - 5.55 |
| 52-Week Range | 3.34 - 5.82 |
| Beta | 0.39 |
About ICCC
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides Ca...
Industry Biotechnology
Sector Healthcare
IPO Date May 5, 1987
Employees 69
Stock Exchange NASDAQ
Ticker Symbol ICCC
Website https://immucell.com
9 months ago
+0%
ImmuCell shares are trading higher after the compa...
Unlock content with
Pro Subscription
